The recent identification of patients with both  LRRK2 and GBA1 mutations who exhibit PD symptoms at an earlier age compared to carriers of single LRRK2 and GBA1 mutations22–24 led us to examine possible mechanistic convergences of LRRK2 and GBA1 in PD pathogenesis. The gene discussed is LRRK2; the disease is Parkinson disease.